Trends in utilization of FDA expedited drug development and approval programs, 1987-2014: cohort study

Objective To evaluate the use of special expedited development and review pathways at the US Food and Drug Administration over the past two decades. Design Cohort study. Setting FDA approved novel therapeutics between 1987 and 2014. Population Publicly available sources provided each drug’s year of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesselheim, Aaron S, Wang, Bo, Franklin, Jessica M, Darrow, Jonathan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580726/
https://www.ncbi.nlm.nih.gov/pubmed/26400751
http://dx.doi.org/10.1136/bmj.h4633

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580726/
https://www.ncbi.nlm.nih.gov/pubmed/26400751
http://dx.doi.org/10.1136/bmj.h4633

Ejemplares similares